This topic contains a solution. Click here to go to the answer

Author Question: The pretest-posttest nonequivalent control group design reduces the threat of assignment bias and ... (Read 122 times)

jilianpiloj

  • Hero Member
  • *****
  • Posts: 521
The pretest-posttest nonequivalent control group design reduces the threat of assignment bias and limits time-related threats and therefore is a quasi-experimental design.
 
  a. True
  b. False
  Indicate whether the statement is true or false

Question 2

A research study that does not have random assignment can still be an experiment if there is a proper control group.
 
  a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

6ana001

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

True

Answer to Question 2

False




jilianpiloj

  • Member
  • Posts: 521
Reply 2 on: Jun 19, 2018
Excellent


hramirez205

  • Member
  • Posts: 345
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

There are over 65,000 known species of protozoa. About 10,000 species are parasitic.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

Cocaine was isolated in 1860 and first used as a local anesthetic in 1884. Its first clinical use was by Sigmund Freud to wean a patient from morphine addiction. The fictional character Sherlock Holmes was supposed to be addicted to cocaine by injection.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library